Savient Investor Asks 2nd Circ. To Reopen Fraud Case
A Savient Pharmaceuticals Inc. investor whose stock value dropped after the company revealed serious incidents related to an experimental drug asked the Second Circuit on Tuesday to reopen his class action,...To view the full article, register now.
Already a subscriber? Click here to view full article